Asia-Pacific
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Sponsored
Sponsored
-
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office explains what types of bio inventions are deemed eligible for patent protection in Japan and draws comparisons with US practice -
Sponsored by Shiga International Patent OfficeThe Japan Patent Office has published additional case examples designed to clarify the patentability of AI-related technology. Fumio Takahashi of Shiga International Patent Office explains the new guidance
-
Sponsored by Wanhuida Intellectual PropertyA ruling on the inventiveness of a compound patent for a prostate cancer therapeutic could help create uniform jurisprudence regarding the examination of pharmaceutical patents, says Guan Yue of Wanhuida Intellectual Property
-
Sponsored by Tilleke & GibbinsGiang Hoang Bach of T&G Law Firm LLC, the local associate firm of Tilleke & Gibbins, considers why administrative measures dominate intellectual property rights infringement responses in Vietnam
-
Sponsored by Tilleke & GibbinsRochmali Zultan and Annisa Syaharani of Tilleke & Gibbins say a Constitutional Court decision could inspire parties with trademark interests to pursue the revocation of intellectual property law provisions and lead to legal uncertainty
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula, Abhishek Nangia, and Shakti Priyan Nair of RNA, Technology and IP Attorneys outline various progressive and business-friendly changes under the Jan Vishwas (Amendment of Provisions) Act, 2023, but identify several potential issues
